KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Net Cash Flow (2017 - 2025)

Twist Bioscience (TWST) has disclosed Net Cash Flow for 9 consecutive years, with -$34.4 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 586.24% to -$34.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$73.3 million through Dec 2025, down 62.79% year-over-year, with the annual reading at -$43.8 million for FY2025, 27.25% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$34.4 million at Twist Bioscience, down from -$18.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $216.0 million in Q1 2022, with the low at -$274.2 million in Q4 2021.
  • Average Net Cash Flow over 5 years is -$10.0 million, with a median of -$10.3 million recorded in 2021.
  • The sharpest move saw Net Cash Flow skyrocketed 327.75% in 2022, then crashed 1324.52% in 2024.
  • Over 5 years, Net Cash Flow stood at -$274.2 million in 2021, then surged by 77.6% to -$61.4 million in 2022, then surged by 66.99% to -$20.3 million in 2023, then skyrocketed by 75.25% to -$5.0 million in 2024, then tumbled by 586.24% to -$34.4 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$34.4 million, -$18.6 million, and -$9.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.